In 2018，under the overall grasp of the “13th Five-Year Plan”，Henan Biomedical Industry implemented taxation，and carried out “consistency” evaluation and other measures. The growth rate of added value of biomedical industry reached 14.6%，which was higher than the overall growth rate of strategic emerging industries by 2.4 percentage points. However，in the process of development，there are also problems such as weak product competitiveness，high capital pressure of enterprises，and increased cost of raw materials. With the development of economy and society and the improvement of people's health requirements，the bio-pharmaceutical industry has ushered in new development opportunities and faces new challenges. In order to build the “Healthy Henan” and promote the high-quality development of Henan bio-pharmaceutical industry，we must adhere to technological innovation and product innovation，guide the establishment of special funds，and consolidate the talent base.